EGRX

Globeflex Capital’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-73,205	Closed	-$3.25M	–	542
2022 Q2	$3.25M	Buy	73,205 +32,000	+78%	+$1.42M	0.79%	19
2022 Q1	$2.04M	Hold	41,205	–	–	0.41%	56
2021 Q4	$2.1M	Hold	41,205	–	–	0.43%	52
2021 Q3	$2.3M	Sell	41,205 -1,152	-3%	-$64.2K	0.5%	42
2021 Q2	$1.81M	Buy	42,357 +8,094	+24%	+$346K	0.33%	91
2021 Q1	$1.43M	Hold	34,263	–	–	0.26%	124
2020 Q4	$1.6M	Buy	34,263 +713	+2%	+$33.2K	0.34%	81
2020 Q3	$1.43M	Buy	33,550 +1,848	+6%	+$78.5K	0.38%	70
2020 Q2	$1.52M	Buy	31,702 +12,951	+69%	+$621K	0.39%	61
2020 Q1	$863K	Hold	18,751	–	–	0.27%	129
2019 Q4	$1.13M	Buy	18,751 +9,873	+111%	+$593K	0.21%	159
2019 Q3	$502K	Hold	8,878	–	–	0.11%	289
2019 Q2	$494K	Hold	8,878	–	–	0.1%	290
2019 Q1	$448K	Buy	8,878 +1,378	+18%	+$69.5K	0.09%	309
2018 Q4	$302K	Hold	7,500	–	–	0.07%	342
2018 Q3	$520K	Sell	7,500 -3,700	-33%	-$257K	0.1%	292
2018 Q2	$847K	Sell	11,200 -19,700	-64%	-$1.49M	0.17%	203
2018 Q1	$1.63M	Buy	30,900 +4,682	+18%	+$247K	0.34%	86
2017 Q4	$1.4M	Buy	+26,218	New	+$1.4M	0.39%	65
2017 Q1	–	Sell	-12,700	Closed	-$1.01M	–	557
2016 Q4	$1.01M	Buy	+12,700	New	+$1.01M	0.25%	152
2016 Q3	–	Sell	-8	Closed	–	–	556
2016 Q2	$0	Hold	8	–	–	﹤0.01%	531
2016 Q1	$0	Sell	8 -4,905	-100%	–	﹤0.01%	501
2015 Q4	$436K	Buy	4,913 +9	+0.2%	+$799	0.12%	245
2015 Q3	$363K	Buy	4,904 +4,900	+122,500%	+$363K	0.08%	314
2015 Q2	$0	Buy	+4	New	–	﹤0.01%	597